Pharmaceutical Manufacturing, cGMP, Quality Assurance, and Unit Operations Notes

Fundamentals of Pharmaceutical Manufacturing & Organization

• Manufacturing Pharmacy: Advanced course dealing with the technology of official and non-official products manufactured on a semi-commercial and commercial scale.

• Industrial Pharmacy: Pharmaceutical research and manufacturing enterprises providing medicines in pre-fabricated or ready-to-take forms.

• Official Products: Listed in official compendia such as the USP NF and the Philippine National Drug Formulary.

• Commercialization: Requires product distribution, marketing, advertising, and retail sale in drugstores.

• Compounding vs. Manufacturing:

  • Compounding (NABP): Small-scale preparation, mixing, packaging, or labeling resulting from a practitioner's prescription or initiative; non-commercial and assigned a Beyond-Use Date.

  • Manufacturing: Large-scale production, propagation, processing, or synthesis for commercial resale; assigned an Expiration Date.

• Basic Elements of Business Organization:

  • Manpower: Production workforce.

  • Money: Financial capital.

  • Machines: Manufacturing equipment.

  • Methods: Standard Operating Procedures (SOPs).

Organizational Management & Hierarchy

• Core Elements of Organizational Structure:

  • Division of responsibility (obligation/duty).

  • Delegation of authority.

  • Interrelationship of component functions to ensure harmonious teamwork.

• Primary Tools for Governance:

  • Organizational Planning (Chart): Illustrates administrative hierarchy; aids in identifying operational overlaps and structural weaknesses, though it cannot reflect specific policies or delegated authority.

  • Position Description: Details specific job duties.

  • Organizational Manual: Serves as a comprehensive management guide combining charts and position descriptions.

• Management Levels:

  • Level I (Board of Trustees / Board of Directors): Represents stockholders, safeguards assets, and sets overarching business policies.

  • Level II (President): Executes active planning, coordination, and operational control under board policies.

  • Level III (Vice Presidents, General Managers, Department Managers): Directs specific operational divisions.

• Line vs. Staff Functions:

  • Line: Direct scalar chain of command holding authority to execute primary business objectives.

  • Staff: Advisory or support entities supplying services and information to the line (e.g., Quality Control).

Research and Development Stages

• Preliminary Stage: Focuses on market analysis, scientific literature review, patent search, and raw material selection.

• Applied Research Stage: Involves chemical synthesis, process development, analytical method design, and cost estimation.

• Clinical Research Stage: Encompasses scale-up manufacturing requirements, labeling research, clinical trial coordination, patent application, and formulation stability testing.

Current Good Manufacturing Practice (cGMP) & Quality Principles

• cGMP Standard: Regulatory system mandated by the USFDA and enforced locally via Administrative order no. 220 s. 1974 to ensure products are consistently produced to specified quality standards.

• Core Objective: Guarantee the safety, identity, purity, potency, and quality of drug products.

• Primary Operational Areas of Concern:

  • Contamination & Cross-Contamination: Prevented via dedicated facilities (e.g., separating penicillin from non-penicillin processing), strict SOPs, air filtration, and laminar flow hoods.

  • Personnel: Hygienic practices, protective garments, medical clearance, and ongoing cGMP training.

  • Buildings: Layout designed for logical workflow, sanitation, proper ventilation, and pest control.

  • Equipment: Constructed with non-reactive, non-additive, and non-absorptive contact surfaces; logged and assigned distinct identification numbers.

Quality Control and Quality Assurance Operations

• Quality Control (QC): Direct operational testing group that establishes component and product specifications; failure to meet specifications leads to an Out of Specification (OOS) disposition.

• Quality Assurance (QA): Systematic monitoring group ensuring that facility systems, validation protocols, and SOPs consistently comply with quality standards.

• Five Key QC Sub-Sections:

  • Specification & Assay Development: Establishes testing standards for raw materials, packaging components, and finished products.

  • Central Release: Audits production/batch records, manages retention samples, handles customer complaints, and oversees returned goods.

  • Chemical Control: Performs quantitative analytical assays and stability testing.

  • Plant Inspection: Monitors environmental conditions, warehouse storage, line clearance, and in-process controls.

  • Biological-Microbiological Control: Conducts sterility, pyrogenicity, microbial limits, and safety/toxicity testing.

Regulatory Standards, Retention, and Storage Requirements

• Retention Sample Specifications: Reserved samples must be stored in locked areas matching market conditions; minimum quantity is $2$\times required testing volume or $2$ final labeled containers, retained for at least $2$\,\text{years} post-distribution or $1$\,\text{year} past expiration date.

• Record & Component Retention Periods:

  • Components: $2$\,\text{years} post-distribution or $1$\,\text{year} past drug expiration.

  • Finished Products / Drug Records: $2$\,\text{years} post-distribution or $1$\,\text{year} past drug expiration.

  • Cosmetic Records: Minimum of $3$\,\text{years} post-manufacture.

• Compendial Storage Temperature Classifications:

  • Freezer: $-25^\circ\text{C}$ to $-10^\circ\text{C}$

  • Cold: Not exceeding $8^\circ\text{C}$

  • Refrigerator: Controlled $2^\circ\text{C}$ to $8^\circ\text{C}$

  • Cool: $8^\circ\text{C}$ to $15^\circ\text{C}$

  • Controlled Room Temperature: $20^\circ\text{C}$ to $25^\circ\text{C}$ (excursions allowed between $15^\circ\text{C}$ and $30^\circ\text{C}$)

  • Warm: $30^\circ\text{C}$ to $40^\circ\text{C}$

  • Excessive Heat: Above $40^\circ\text{C}$

Pharmaceutical Quality System (ICH Q10) & Quality Risk Management (ICH Q9)

• ICH Q10 Lifecycle Objectives:

  • Achieve Product Realization.

  • Establish and Maintain a State of Control.

  • Facilitate Continual Improvement.

• PQS Lifecycle Elements: Process performance/product quality monitoring, CAPA system, Change management system, Management review.

• ICH Q9 Quality Risk Management (QRM): Systematic process for risk assessment (identification, analysis, evaluation), risk control (reduction, acceptance), risk review, and risk communication.

• Common QRM Analytical Tools:

  • Fishbone / Ishikawa Diagram: Cause and effect analysis.

  • FMEA / FMECA: Failure Mode (and Criticality) Effects Analysis for prioritizing operational risk scores.

  • Fault Tree Analysis (FTA): Root cause analysis of system failures.

  • HACCP: Hazard Analysis and Critical Control Points ($7$-step preventive system).

Good Documentation Practice (GDP) & Good Laboratory Practice (GLP)

• GDP Principles:

  • Entries made in permanent, indelible blue or black ink.

  • Single-line strike-through for error correction (initialed, dated, with reason); no correction fluids or erasure.

  • Standardized page numbering format ($\text{Page X of Y}$).

• GLP Framework (21 CFR Part 58 / OECD):

  • Governs nonclinical safety and environmental safety testing.

  • Key roles: Sponsor, Facility Management, Study Director (overall technical control), and Quality Assurance Unit (QAU).

  • Requires formal SOPs, equipment maintenance/calibration logs, and certified reference standards.

Unit Operations: Comminution and Milling Technologies

• Comminution Forces:

  • Attrition: Rubbing action between surfaces (e.g., mortar and pestle).

  • Rolling: Compression/shear via heavy rolling members.

  • Impact: High-speed striking (e.g., hammer mill).

  • Cutting/Shearing: Sharp blades for fibrous plant materials (e.g., cutter mill).

• Specialized Milling Equipment:

  • Hammer Mill: Rotating beaters breaking material by impact.

  • Ball / Pebble Mill: Tumbling action producing attrition and impact; operates in a closed horizontal cylinder.

• Fluid Energy Mill (Jet Mill / Micronizer): High-velocity gas streams create violent turbulence and inter-particle collisions; no moving mechanical parts; ideal for thermolabile and ultra-fine particle size reduction.

Unit Operations: Mixing, Dispersing, and Processing Equipment

• Solid Blenders: Double-cone, twin-shell ($\text{V}$-blender), ribbon mixer (fixed shell), planetary/sigma-blade mixers.

• Fluid Agitators:

  • Propeller Mixers: High-speed axial flow ($300$\text{--}$1750$\,\text{rpm}).

  • Turbine Mixers: Radial/axial flow for high viscosity fluids in large volumes ($500$\text{--}$1000$\,\text{gal}).

  • Anchor Mixers: Low-speed (<$50$\,\text{rpm}) low-shear mixing without overshearing.

  • Scraped-Surface Agitators: Anchor frames with flexible wipers for jacketed vessels requiring heat transfer.

• High-Shear Homogenizers & Emulsifiers:

  • Rotor/Stator Systems & Colloid Mills: High-shear fluid processing through narrow gaps between stationary and rotating parts.

  • Piston Homogenizer: Ultra-high pressure system producing extremely fine emulsions and suspensions.

  • Microfluidizer: Uses micro-channels under high pressure to prepare microemulsions and liposomes.